Position in RDY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$156,897
-$38,623 QoQ
Shares Held
10,828
-23.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#171
of 238 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $3,280,030 across 8 Drug Manufacturers - Specialty & Generic names. RDY ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
10,866 | $780,830 | |
| 2 | HLN |
Haleon plc
|
76,122 | $710,216 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,220 | $661,032 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,101 | $454,964 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
16,734 | $268,244 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,273 | $209,307 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
This page
|
10,828 | $156,897 | |
| 8 | ALVO |
Alvotech
|
10,445 | $38,540 |
All Filings in RDY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,897 | 10,828 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $195,520 | 14,117 | Shares | Other | 2026-05-15 | |
| 2025-06-30 | $163,601 | 10,885 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $133,627 | 10,131 | Shares | Other | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||